Rotigotine and specific non-motor symptoms of Parkinson's disease: Post hoc analysis of RECOVER

Parkinsonism and Related Disorders

Volumn 19, Issue 7, 2013, Pages 660-665

  Ray Chaudhuri, K ^a   Martinez Martin, Pablo ^b   Antonini, Angelo ^c   Brown, Richard G ^d   Friedman, Joseph H ^e   Onofrj, Marco ^f   Surmann, Erwin ^g   Ghys, Liesbet ^g   Trenkwalder, Claudia ^h  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c IRCCS SAN CAMILLO HOSPITAL   (Italy)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e BROWN UNIVERSITY   (United States)

^f UNIVERSITY OF CHIETI   (Italy)

^g UCB PHARMA   (Belgium)

^h UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Fatigue; Mood; Non motor symptoms; Parkinson's disease; Rotigotine

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; PLACEBO; ROTIGOTINE;

ADULT; AGED; APATHY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG DOSE TITRATION; EXPLORATORY RESEARCH; FATIGUE; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MOTOR DYSFUNCTION; NON MOTOR SYMPTOMS SCALE; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PARKINSON DISEASE; POST HOC ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SLEEP DISORDER; SYMPTOM; TREATMENT DURATION;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; APATHY; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; SLEEP DISORDERS; TETRAHYDRONAPHTHALENES; THIOPHENES;

EID: 84878261050     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.02.018     Document Type: Article

References (33)

1. Antonini A., Barone P., Marconi R., Morgante L., Zappulla S., Pontieri F.E., et al. The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. JNeurol 2012, 259:2621-2631.
2. Zesiewicz T.A., Sullivan K.L., Arnulf I., Chaudhuri K.R., Morgan J.C., Gronseth G.S., et al. Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2010, 74:924-931.
3. Martinez-Martin P., Rodriguez-Blazquez C., Kurtis M.M., Chaudhuri K.R. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov Disord 2011, 26:399-406.
4. Chaudhuri K.R., Schapira A.H. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009, 8:464-474.
5. Chaudhuri K.R., Healy D.G., Schapira A.H. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006, 5:235-245.
6. McKinlay A., Grace R.C., Dalrymple-Alford J.C., Anderson T., Fink J., Roger D. Aprofile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia. Parkinsonism & Relat Disord 2008, 14:37-42.
7. Barone P. Neurotransmission in Parkinson's disease: beyond dopamine. Eur J Neurol 2010, 17:364-376.
8. Chaudhuri K.R. The dopaminergic basis of sleep dysfunction and non motor symptoms of Parkinson's disease: evidence from functional imaging. Exp Neurol 2009, 216:247-248.
9. Seppi K., Weintraub D., Coelho M., Perez-Lloret S., Fox S.H., Katzenschlager R., et al. The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson's disease. Mov Disord 2011, 26(Suppl. 3):S42-S80.
10. Boroojerdi B., Wolff H.M., Braun M., Scheller D.K. Rotigotine transdermal patch for the treatment of Parkinson's disease and restless legs syndrome. Drugs Today (Barc) 2010, 46:483-505.
11. Elshoff J.P., Braun M., Andreas J.O., Middle M., Cawello W. Steady-state plasma concentration profile of transdermal rotigotine: an integrated analysis of three, open-label, randomized, phase I multiple dose studies. Clin Ther 2012, 34:966-978.
12. Trenkwalder C., Kies B., Rudzinska M., Fine J., Nikl J., Honczarenko K., et al. Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 2011, 26:90-99.
13. Chaudhuri K.R., Martinez-Martin P., Brown R.G., Sethi K., Stocchi F., Odin P., et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 2007, 22:1901-1911.
14. Martinez-Martin P., Rodriguez-Blazquez C., Abe K., Bhattacharyya K.B., Bloem B.R., Carod-Artal F.J., et al. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 2009, 73:1584-1591.
15. Honig H., Antonini A., Martinez-Martin P., Forgacs I., Faye G.C., Fox T., et al. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Mov Disord 2009, 24:1468-1474.
16. Naidu Y., Tluk S., Martin A., Jacobs S., Davidson C., Richards C., et al. Intitation of apomorphine infusion in advanced Parkinson's disease and effect on non motor symptoms compared to noninvasive strategies. Mov Disord 2009, 24:S360.
17. Rosnow R.L., Rosenthal R., Rubin D.B. Contrasts and correlations in effect-size estimation. Psychol Sci 2000, 11:446-453.
18. Friedman J.H., Brown R.G., Comella C., Garber C.E., Krupp L.B., Lou J.S., et al. Fatigue in Parkinson's disease: a review. Mov Disord 2007, 22:297-308.
19. Friedman J.H., Chou K.L. Sleep and fatigue in Parkinson's disease. Parkinsonism & Relat Disord 2004, 10(Suppl. 1):S27-S35.
20. Ray Chaudhuri K., Martinez-Martin P., Rolfe K.A., Cooper J., Rockett C.B., Giorgi L., et al. Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease. Eur J Neurol 2012, 19:105-113.
21. Barone P., Antonini A., Colosimo C., Marconi R., Morgante L., Avarello T.P., et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009, 24:1641-1649.
22. Abe K., Takanashi M., Yanagihara T., Sakoda S. Pergolide mesilate may improve fatigue in patients with Parkinson's disease. Behav Neurol 2001, 13:117-121.
23. Lou J.S., Kearns G., Benice T., Oken B., Sexton G., Nutt J. Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study. Mov Disord 2003, 18:1108-1114.
24. Schifitto G., Friedman J.H., Oakes D., Shulman L., Comella C.L., Marek K., et al. Fatigue in levodopa-naive subjects with Parkinson disease. Neurology 2008, 71:481-485.
25. Schulte E.C., Winkelmann J. When Parkinson's disease patients go to sleep: specific sleep disturbances related to Parkinson's disease. JNeurol 2011, 258:S328-S335.
26. Reijnders J.S., Ehrt U., Weber W.E., Aarsland D., Leentjens A.F. Asystematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 2008, 23:183-189. quiz 313.
27. Weintraub D., Burn D.J. Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord 2011, 26:1022-1031.
28. Barone P., Poewe W., Albrecht S., Debieuvre C., Massey D., Rascol O., et al. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010, 9:573-580.
29. Barone P., Scarzella L., Marconi R., Antonini A., Morgante L., Bracco F., et al. Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study. JNeurol 2006, 253:601-607.
30. Rabinak C.A., Nirenberg M.J. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 2010, 67:58-63.
31. Kim H.J., Park S.Y., Cho Y.J., Hong K.S., Cho J.Y., Seo S.Y., et al. Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. JNeurol Sci 2009, 287:200-204.
32. Martinez-Martin P., Falup Pecurariu C., Odin P., van Hilten J.J., Antonini A., Rojo-Abuin J.M., et al. Gender-related differences in the burden of non-motor symptoms in Parkinson's disease. JNeurol 2012, 259:1639-1647.
33. Chaudhuri K.R., Martinez-Martin P., Schapira A.H., Stocchi F., Sethi K., Odin P., et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006, 21:916-923.